Toshihide Komatsubara1, Koji Koinuma2, Yasuyuki Miyakura2,3, Hisanaga Horie2, Mitsuaki Morimoto2, Homare Ito2, Alan K Lefor2, Naohiro Sata2, Noriyoshi Fukushima4. 1. Department of Surgery, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan. edy-sot@nifty.com. 2. Department of Surgery, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan. 3. Department of Surgery, Saitama Medical Center Jichi Medical University, Amanuma-cho, Saitama, Saitama, 330-0834, Japan. 4. Department of Pathology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan.
Abstract
PURPOSE: Endocrine cell carcinoma, according to the Japanese classification criteria for colorectal cancer, corresponds to neuroendocrine carcinoma (NEC) and mixed adenoneuroendocrine carcinoma (MANEC), as defined in the 2010 World Health Organization (WHO) classification. We retrospectively reviewed the clinical features of patients with these tumors diagnosed and treated at our institution. METHODS: The clinicopathological features of endocrine cell carcinomas of the colon and rectum diagnosed by neuroendocrine markers from January 2000 to December 2012 were retrospectively evaluated in 12 patients. RESULTS: Surgical specimens were obtained from eight of the 12 patients. MANEC was diagnosed in six patients and NEC in one. One tumor was unclassifiable. The tumors were not resected in four patients, and all died within 3 months. Of the eight patients who underwent resection, four received an R0 resection, two of whom underwent adjuvant chemotherapy and survived more than 5 years. One patient who underwent an R2 resection and continuous chemotherapy survived for 53 months. One patient with NEC underwent surgery and radiotherapy, and died 17 months later. CONCLUSION: Most endocrine cell carcinomas of the colon and rectum reviewed were MANECs. Though their prognosis was generally poor, chemotherapy may be effective in some patients.
PURPOSE:Endocrine cell carcinoma, according to the Japanese classification criteria for colorectal cancer, corresponds to neuroendocrine carcinoma (NEC) and mixed adenoneuroendocrine carcinoma (MANEC), as defined in the 2010 World Health Organization (WHO) classification. We retrospectively reviewed the clinical features of patients with these tumors diagnosed and treated at our institution. METHODS: The clinicopathological features of endocrine cell carcinomas of the colon and rectum diagnosed by neuroendocrine markers from January 2000 to December 2012 were retrospectively evaluated in 12 patients. RESULTS: Surgical specimens were obtained from eight of the 12 patients. MANEC was diagnosed in six patients and NEC in one. One tumor was unclassifiable. The tumors were not resected in four patients, and all died within 3 months. Of the eight patients who underwent resection, four received an R0 resection, two of whom underwent adjuvant chemotherapy and survived more than 5 years. One patient who underwent an R2 resection and continuous chemotherapy survived for 53 months. One patient with NEC underwent surgery and radiotherapy, and died 17 months later. CONCLUSION: Most endocrine cell carcinomas of the colon and rectum reviewed were MANECs. Though their prognosis was generally poor, chemotherapy may be effective in some patients.
Entities:
Keywords:
Mixed adenoneuroendocrine carcinoma; Neuroendocrine carcinoma; WHO classification
Authors: Marco Volante; Maria Pia Brizzi; Antongiulio Faggiano; Stefano La Rosa; Ida Rapa; Anna Ferrero; Gelsomina Mansueto; Luisella Righi; Silvana Garancini; Carlo Capella; Gaetano De Rosa; Luigi Dogliotti; Annamaria Colao; Mauro Papotti Journal: Mod Pathol Date: 2007-09-14 Impact factor: 7.842
Authors: Anja Rinke; Hans-Helge Müller; Carmen Schade-Brittinger; Klaus-Jochen Klose; Peter Barth; Matthias Wied; Christina Mayer; Behnaz Aminossadati; Ulrich-Frank Pape; Michael Bläker; Jan Harder; Christian Arnold; Thomas Gress; Rudolf Arnold Journal: J Clin Oncol Date: 2009-08-24 Impact factor: 44.544
Authors: Paurush Ambesh; Joseph Weissbrot; Sabina Ratner; Ankur Sinha; Ravikaran Patti; Jasminka Balderacchi; Michael Marcelin; Lawrence Wolf; Stephan Kamholz Journal: J Investig Med High Impact Case Rep Date: 2017-12-21
Authors: Marina Morais; André Costa Pinho; Ana Marques; Joanne Lopes; Alexandre Duarte; Pedro Correia da Silva; José Manuel Lopes; J Costa Maia Journal: Case Rep Surg Date: 2016-07-25
Authors: Sang Ho Shin; Sae Hee Kim; Sung Hee Jung; Ji Woong Jang; Min Seok Kang; Sang Il Kim; Ji Hye Kim; Jun Ho Lee Journal: Ann Coloproctol Date: 2017-02-28
Authors: Melissa Frizziero; Bipasha Chakrabarty; Bence Nagy; Angela Lamarca; Richard A Hubner; Juan W Valle; Mairéad G McNamara Journal: J Clin Med Date: 2020-01-19 Impact factor: 4.241